[1]
Li, J. 2023. In vivo and in vitro action mechanism of treatment of glucocorticoid-induced osteoporosis by regulation of osteoprotegerin/receptor activator of nuclear factor-κB pathways by denshensu: Treatment of glucocorticoid-induced osteoporosis by denshensu. Cellular and Molecular Biology. 69, 10 (Oct. 2023), 67–74. DOI:https://doi.org/10.14715/cmb/2023.69.10.9.